Every recall we track for Tris Pharma Inc. — 8 in all, from 2017–2019 — plus the complaints and injury reports the public filed about them. 1 is rated “stop using now”.
Recalls on record by year — 8 drug.
Tris Pharma recalls Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension due to high drug levels that could cause serious harm. This Rx-only product was manufactured with NDC 27808-086-02, lot 14079, expiring 10/2021.
Tris Pharma recalls infant ibuprofen oral suspension with possible higher concentration than labeled. Consumers should check product details and contact the company for guidance.
Tris Pharma recalls infants' concentrated ibuprofen oral suspension with potential higher ibuprofen concentration. Consumers should check product labels for specific lot numbers and expiration dates to avoid risks.
8 recalls from Tris Pharma Inc. are on record with U.S. safety agencies, from 2017–2019.
Tris Pharma Inc. recalls Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, (equivalent to 10 mg hydrocodone, dated Jul 11, 2019. Every Tris Pharma Inc. recall is listed on this page, newest first.
The most common reasons on record: Superpotent Drug: recalled lots may have higher concentration of ibuprofen. (3).
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.
